Currently, the treatment of advanced breast cancer, especially in the brain metastasis-associated and drug-resistant patient population, remains a difficult clinical challenge. volume and that lapatinib also works on breast cancer stem cells, which are encouraging results. With its small molecule and dual-targeting characteristics, lapatinib offers new hope for the treatment of patients with brain metastases.